Body Contouring in the Era of GLP-1 Therapy: Are We Ignoring Tissue Biology?

Abstract

Get full access to this article

View all access options for this article.

References

Parkman HP, Rim DS, Anolik JR, Dadparvar S, Maurer AH. Glucagonlike peptide-1 receptor agonists: The good, the bad, and the ugly-benefits for glucose control and weight loss with side effects of delaying gastric emptying. J Nucl Med Technol. 2024;52(1):3–7. doi: 10.2967/jnmt.123.266800

Albanese

Tomaselli

Delia

Tambasco

. GLP-1 Agonists in aesthetic surgery: Implications for perioperative outcomes and body contouring procedures. Aesthetic Plast Surg. 2025;49(17):4910‐4916. doi:10.1007/s00266-025-05015-3

D'Ettorre

Bracaglia

Gentileschi

Tambasco

. Micro- and macroscopic tissue modifications after bariatric surgery: Effects of different procedures-a pilot study. Aesthetic Plast Surg. 2013;37(4):846‐848. doi:10.1007/s00266-013-0175-4

Haykal

Hersant

Cartier

Meningaud

. The role of GLP-1 agonists in esthetic medicine: Exploring the impact of semaglutide on body contouring and skin health. J Cosmet Dermatol. 2025;24(2):e16716. doi:10.1111/jocd.16716

Rahman

Webb

Sadeghi-Esfahlani

, et al. Disruptions in aesthetic medicine: A global analysis of GLP-1 agonists using punctuated equilibrium framework. Plast Reconstr Surg. 2026;157(1):84‐102. doi:10.1097/PRS.0000000000012307